INNITIUS is a medical device company that develops the Fine Birth, a portable device based on torsional wave technology for monitoring labor in pregnant women and diagnosing conditions associated with changes in tissue consistency. The device enables healthcare providers to differentiate between false pre-term labor and true pre-term labor, improving clinical decision-making during pregnancy and reducing unnecessary interventions. The torsional wave technology non-invasively assesses cervical tissue properties, providing objective measurements that complement traditional clinical assessments. INNITIUS technology addresses the significant clinical challenge of accurately predicting and managing pre-term labor, which affects millions of pregnancies worldwide. Founded in 2007 and headquartered in Derio, Spain, the company has raised approximately $5.4 million in seed funding from investors including EIT Health, EIC Fund, Nara Capital, and Clave.
INNITIUS
SeedINNITIUS is a medical device company that develops the Fine Birth, a portable device based on torsional wave technology for monitoring labor in pregnant women and diagnosing conditions associated with changes in tissue consistency. The device enables healthcare providers to differentiate between false pre-term labor and true pre-term labor, improving clinical decision-making during pregnancy and reducing unnecessary…
About
Business model
Wearable Technology > Health and Wellness Devices > Women Health > Pregnancy Care,
Disease Self Management > Women Health > Therapy > Reproductive Health > Pregnancy > Device,
Women Health > Medical Devices > Monitoring > Pregnancy and Labor > Clinic Based
Team background
College Wise > University College London
Institutional investors
Latest coverage
📰 Browse funding news — rounds, valuations, and market moves for founders.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.